Pure Global

Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1 - Trial NCT06381102

Access comprehensive clinical trial information for NCT06381102 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Miami and is currently Recruiting. The study focuses on Healthy. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06381102
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06381102
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1
How Does the Length of Pulse Trains and Pulse Intervals Affect Tolerability With Transcutaneous Auricular Vagus Nerve Stimulation?

Study Focus

Healthy

transcutaneous auricular vagus nerve stimulation 30/30

Interventional

device

Sponsor & Location

University of Miami

Miami, United States of America

Timeline & Enrollment

N/A

Apr 13, 2024

Oct 01, 2024

30 participants

Primary Outcome

Tolerability measured by tolerability questionnaire,Tolerability measured by self-report

Summary

The purpose of this research study is to investigate the effects of different forms of a
 gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular
 vagus nerve stimulation (taVNS). The research team is interested in how the different forms
 affect comfort and tolerability, as well as how well it works.

ICD-10 Classifications

Obesity
Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Healthy person accompanying sick person
Lifestyle-related condition
Malnutrition

Data Source

ClinicalTrials.gov

NCT06381102

Device Trial